Compare · Healing peptide
BPC-157 vs Thymosin Beta-4
Both are healing peptide compounds. Here's how they line up on the evidence — graded the same way.
| BPC-157 | Thymosin Beta-4 | |
|---|---|---|
| Evidence | Animal only | Preliminary human |
| Class | Healing peptide | Healing peptide |
| Summary | A synthetic peptide marketed for healing, but human data is limited to a few tiny uncontrolled studies. It is unapproved and banned in sport. | Full-length thymosin beta-4 has genuine human trials for eye-surface and wound healing, but the evidence is small, sponsor-driven, and largely missed its primary endpoints. |
| Full profile → | Full profile → |
BPC-157
BPC-157 is one of the most hyped "healing peptides" in the recovery and longevity world. Strip away the marketing, and the human evidence is remarkably thin.
Thymosin Beta-4
Thymosin beta-4 is unusual among "research peptides" because it has actually been through registered, peer-reviewed human trials. That is the honest selling point — and also where the story gets complicated, because the best-studied use has now missed its primary endpoint in two separate Phase 3…